旺山旺水-B(02630)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02630 旺山旺水-B

未开盘 07-21 16:08:04

66.600

+14.500

+27.83%

最高67.350	最低52.000	成交量10.05万
今开52.000	昨收52.100	日振幅29.46%
总市值111.89亿	流通市值111.22亿	总股本1.68亿
成交额603.05万	换手率0.06%	流通股本1.67亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02630","market":"HK","secType":"STK","nameCN":"旺山旺水-B","latestPrice":66.6,"timestamp":1784621284357,"preClose":52.1,"halted":0,"volume":100500,"delay":0,"changeRate":0.27831094049904015,"floatShares":167000000,"shares":168000000,"eps":-2.699747880707973,"marketStatus":"未开盘","change":14.5,"latestTime":"07-21 16:08:04","open":52,"high":67.35,"low":52,"amount":6030475,"amplitude":0.294626,"askPrice":66.6,"askSize":200,"bidPrice":63.7,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-2.7229216822591145,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784683800000},"marketStatusCode":0,"adr":0,"listingDate":1762358400000,"exchange":"SEHK","adjPreClose":52.1,"openAndCloseTimeList":[[1784597400000,1784606400000],[1784610000000,1784620800000]],"volumeRatio":1.823295,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02630","defaultTab":"news","newsList":[{"id":"2651494184","title":"旺山旺水-B(02630.HK)存仓市值总计53.67亿港元 其中股东向中国证券登记结算香港存入1亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651494184","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651494184?lang=zh_cn&edition=full","pubTime":"2026-07-16 08:09","pubTimestamp":1784160568,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102634088","title":"旺山旺水-B完成境内非上市股份转换为H股，H股数量增至1.67亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1102634088","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102634088?lang=zh_cn&edition=full","pubTime":"2026-07-15 17:52","pubTimestamp":1784109121,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司（旺山旺水-B，股票代码02630）于2026年7月15日公告，完成将100,220,667股境内非上市股份转换为H股。本次转换占此前已发行H股（不包括库藏股）约150.3074%。\n经此次变动，旺山旺水-B在香港联交所上市的已发行H股由2026年6月30日的66,677,133股增至166,897,800股，境内非上市股份余700,000股。公司整体已发行股份达到167,597,800股。\n公司表示，已就本次股份转换事宜获得适当授权，并严格遵守相关上市规则和相关法律法规的规定。公告由董事会秘书兼联席公司秘书郭婷签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"旺山旺水-B完成境内非上市股份转换为H股，H股数量增至1.67亿股","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651459549","title":"旺山旺水-B(02630)完成H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2651459549","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651459549?lang=zh_cn&edition=full","pubTime":"2026-07-15 17:37","pubTimestamp":1784108245,"startTime":"0","endTime":"0","summary":"智通财经APP讯，旺山旺水-B(02630)发布公告，100,220,667股境内未上市股份转换为H股已于2026年7月15日完成，而100,220,667股经转换H股将于2026年7月16日上午九时正开始于联交所上市。参与股东须在完成适用的境内安排程序后，方可进行经转换H股交易。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1467899.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649145716","title":"旺山旺水-B(02630)：联交所就公司H股全流通授出上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2649145716","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649145716?lang=zh_cn&edition=full","pubTime":"2026-07-06 08:10","pubTimestamp":1783296607,"startTime":"0","endTime":"0","summary":"智通财经APP讯，旺山旺水-B(02630)发布公告，公司已收到联交所于2026年7月3日授出的上市批准，准许100,220,667股H股(即将予转换及上市的境内未上市股份的总数)上市及买卖。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1463294.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02630","IPOS","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157143175","title":"旺山旺水-B 6月股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1157143175","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157143175?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:36","pubTimestamp":1783067805,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司于2026年7月3日发布截至2026年6月30日的证券变动月报表。公告显示，报告期内公司总股本和已发行股份数未发生变动。根据公告，公司现有普通股H股66,677,133股，报告期内未发生新增发行、回购或注销活动，至6月底仍维持66,677,133股；同时，在其他非上市普通股方面，也维持在100,920,667股，未发生增减变化。公司注册股本合计为167,597,800股，与上月持平。公司在月报中确认，截至报告期末，公司在公众持股量方面继续符合相关要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647320940","title":"旺山旺水-B(02630)：中国证监会就公司H股全流通申请发出备案通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2647320940","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647320940?lang=zh_cn&edition=full","pubTime":"2026-06-29 17:47","pubTimestamp":1782726430,"startTime":"0","endTime":"0","summary":"智通财经APP讯，旺山旺水-B(02630)公布，中国证监会近期已就实施H股全流通向公司出具了备案通知书。根据备案通知书，公司就10 名股东持有的合计 约1亿股未上市股份实施H股全流通向中国证监会作出的备案已经完成。该等约1亿股H股将于完成有关转换及联交所授出上市批准后于联交所主板上市及买卖。备案通知书的有效期为12个月。若公司希望在备案通知书出具之日起12个月后继续进行转换及上市，则需向中国证监会更新备案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1460403.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145184597","title":"旺山旺水-B授予董事会股份购回授权 规模最高达已发行H股一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1145184597","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145184597?lang=zh_cn&edition=full","pubTime":"2026-06-04 23:01","pubTimestamp":1780585268,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司公告，董事会已提请即将召开的股东大会审议并批准一项股份购回一般性授权，计划于授权有效期内，回购不超过公司已发行H股股份的10%。截至公告所述最后实际可行日期，公司共发行167,597,800股股份，其中包括66,677,133股H股。根据自2025年11月至2026年6月初的市场表现，公司H股曾录得最高每股134.90港元、最低51.00港元的交易区间。凡于暂停过户前登记为公司股东的个人及机构，将享有出席和表决相关授权议案的权利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"旺山旺水-B授予董事会股份购回授权 规模最高达已发行H股一成","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640163128","title":"旺山旺水-B(02630)建议委任国卫为新任核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2640163128","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640163128?lang=zh_cn&edition=full","pubTime":"2026-06-04 22:15","pubTimestamp":1780582501,"startTime":"0","endTime":"0","summary":"智通财经APP讯，旺山旺水-B(02630)发布公告，本公司的现任核数师德勤•关黄陈方会计师行(德勤)将于其当前任期届满后，即本公司将于2026年6月26日举行的年度股东会结束时退任本公司核数师，且不会于年度股东会续聘为本公司核数师。于2026年5月22日，本公司审核委员会召开会议，建议委任国卫会计师事务所有限公司(国卫)为本公司新任核数师。于2026年6月4日，本公司董事会经适当考虑及审核委员会提议，董事会决议建议委任国卫为本公司新任核数师，以接替德勤的退任，自年度股东会结束后生效，直至本公司下届年度股东会结束为止，须待本公司股东于年度股东会上予以批准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450425.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130976830","title":"旺山旺水-B5月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1130976830","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130976830?lang=zh_cn&edition=full","pubTime":"2026-06-04 17:16","pubTimestamp":1780564588,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司于2026年6月4日公布2026年5月股份变动月报表。根据公告，报告期内，公司已发行股份总数、注册股本及库存股份数量均保持不变。公告显示，截至5月31日，旺山旺水-B所发行的H股数为66,677,133股，面值均为人民币1元；非上市股份为100,920,667股，面值同为人民币1元。两类股份在5月均无增加或减少。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117868226","title":"旺山旺水-B强化公司治理与资金内控，多措并举完善董事会监管","url":"https://stock-news.laohu8.com/highlight/detail?id=1117868226","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117868226?lang=zh_cn&edition=full","pubTime":"2026-06-01 21:03","pubTimestamp":1780319039,"startTime":"0","endTime":"0","summary":"截至2025年12月31日止年度，旺山旺水-B在公司治理及内部管控方面全面推进多项升级举措。董事会作为最高决策机构，统筹管理投资及资金运用，并通过财务部等内部部门执行日常经营活动。董事会对此作出解释并采取多项补救措施，包括严格审核资金来源、加强筹资与合规的培训、升级内部管控与审批系统，并在后续报告中对该事件予以说明。公司表示，未来将持续完善公司治理与内部控制体系，确保资金运作的透明与合规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"旺山旺水-B强化公司治理与资金内控，多措并举完善董事会监管","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134189786","title":"旺山旺水-B聚焦2025年度持续关连交易管理，强化董事会监控机制","url":"https://stock-news.laohu8.com/highlight/detail?id=1134189786","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134189786?lang=zh_cn&edition=full","pubTime":"2026-05-25 18:23","pubTimestamp":1779704634,"startTime":"0","endTime":"0","summary":"旺山旺水-B于2026年5月22日就截至2025年12月31日止年度的报告作出补充披露，重点围绕持续关连交易的合规要求与内部流程优化。公司董事长兼首席执行官与管理层向董事会汇报相关补充资料，确保年报内容与此次公告相一致。根据最新披露，董事会与管理层对涉及API及辅助服务采购的持续关连交易进行了审阅，并重申此类交易需获董事会批准，且应遵循公司招股章程中的年度上限规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"旺山旺水-B聚焦2025年度持续关连交易管理，强化董事会监控机制","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146506198","title":"旺山旺水-B 4月无新增发行及股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1146506198","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146506198?lang=zh_cn&edition=full","pubTime":"2026-05-07 06:46","pubTimestamp":1778107580,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司于2026年5月7日披露2026年4月证券变动月报。公告显示，截至2026年4月30日，公司H股股份数为66,677,133股，面值人民币1元，对应注册资本66,677,133元；非上市股份数为100,920,667股，对应注册资本100,920,667元。公司本月底法定/注册股本总额为人民币167,597,800元。报告期内，公司未发生新增发行、购回或注销股份情况，库存股份数维持为0股，股权激励计划与可换股票据等相关事务亦无发行或变动。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631637617","title":"旺山旺水-B(02630.HK)：拟取消监事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2631637617","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631637617?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:37","pubTimestamp":1777552623,"startTime":"0","endTime":"0","summary":"格隆汇4月30日丨旺山旺水-B(02630.HK)公告，公司拟取消公司监事会的设置并废止《苏州旺山旺水生物医药股份有限公司监事会议事规则》。监事会的职权由董事会审核委员会行使，公司各项规章制度中涉及监事会、监事的规定不再适用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260430/32195069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150860148","title":"苏州旺山旺水生物医药2025年收入大幅跃升至1.02亿元 创新药管线带动业务快速扩张 亏损同比扩大至3.57亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1150860148","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150860148?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:29","pubTimestamp":1777552191,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司于报告期内录得显著业绩增长和相应成本投入提升。根据年报披露，截至2025年12月31日止年度，公司实现营业收入约1.02亿元人民币，较2024年度的约0.12亿元人民币上涨约762.9%，主要动力来自核心创新药产品的商业化，以及持续的研发投入与市场拓展。管理层指出，2025年1月采用的受限制股份计划所计提费用约1.84亿元人民币，以及生产和市场费用约0.23亿元人民币为推动亏损扩大的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"苏州旺山旺水生物医药2025年收入大幅跃升至1.02亿元 创新药管线带动业务快速扩张 亏损同比扩大至3.57亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126025375","title":"旺山旺水-B3月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1126025375","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126025375?lang=zh_cn&edition=full","pubTime":"2026-04-08 17:06","pubTimestamp":1775639209,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司于2026年4月8日发布了截至2026年3月31日的股份变动月报表。报告显示，公司本月未发生任何新增发行、回购或注销股份，整体股本维持稳定。苏州旺山旺水生物医药股份有限公司的已发行股本结构包括在香港联合交易所有限公司上市的H股66,677,133股，以及非上市股份100,920,667股。截至报告期末，上述股数均与上月底保持一致，公司注册股本总额为167,597,800股。本次月报由公司董事会秘书兼联席公司秘书郭婷签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624510239","title":"15家企业同日递表港交所；香港中旅、旺山旺水发布2025年年度业绩丨港交所早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2624510239","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624510239?lang=zh_cn&edition=full","pubTime":"2026-04-02 00:10","pubTimestamp":1775059838,"startTime":"0","endTime":"0","summary":"15家企业同日递表港交所；香港中旅、旺山旺水发布2025年年度业绩丨港交所早参","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604023692388969.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604023692388969.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1604","02630","BK1191","00308","BK1164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623535160","title":"旺山旺水-B(02630)发布2025年度业绩，股东应占亏损3.56亿元，同比扩大68.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623535160","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623535160?lang=zh_cn&edition=full","pubTime":"2026-03-31 23:54","pubTimestamp":1774972457,"startTime":"0","endTime":"0","summary":"智通财经APP讯，旺山旺水-B(02630)发布截至2025年12月31日止年度业绩，收入1.02亿元(人民币，下同)，同比增长762.9%;公司拥有人应占亏损3.56亿元，同比扩大68.3%;每股基本亏损2.33元。截至2025年12月31日止年度，营业收入较上一年度实现大幅增长，核心增长动力来源于两部分：一是公司用于治疗男性勃起功能障碍的1类新药昂伟达® (产品代号：TPN171)于2025年7月获批上市后，市场推广和销售成效显著，收入快速增长;二是VV116干混悬剂的呼吸道合胞病毒(RSV)感染适应症License-out专案达成里程碑节点，顺利收到里程碑款项。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423534.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"旺山旺水-B(02630)发布2025年度业绩，股东应占亏损3.56亿元，同比扩大68.3%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140467966","title":"一周港股牛熊榜 | 词元经济政策红利释放，迅策一周升28%；锂价暴涨，赣锋锂业升超27%；绩后暴跌引发IP依赖担忧，泡泡玛特暴跌29%","url":"https://stock-news.laohu8.com/highlight/detail?id=1140467966","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140467966?lang=zh_cn&edition=full","pubTime":"2026-03-27 16:29","pubTimestamp":1774600142,"startTime":"0","endTime":"0","summary":"作为港股词元第一股，迅策凭借先发优势深度卡位。公司股价受此消息提振连升4日，累计涨幅近20%。本周泡泡玛特在业绩发布后的股价剧烈波动。旺山旺水本周下跌30.87%本周旺山旺水股价延续调整态势，周跌幅约10.7%，成交活跃度维持在较低水平。公司将于3月31日披露2025财年年报。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"一周港股牛熊榜 | 词元经济政策红利释放，迅策一周升28%；锂价暴涨，赣锋锂业升超27%；绩后暴跌引发IP依...","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSImain","02477","02630","01772","09992","HSI","01515","07489","03317","HSTECH","02442","02706","02627"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2620295255","title":"旺山旺水－Ｂ(02630.HK)拟3月31日举行董事会会议考虑及批准全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2620295255","media":"中金财经","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620295255?lang=zh_cn&edition=full","pubTime":"2026-03-19 06:57","pubTimestamp":1773874622,"startTime":"0","endTime":"0","summary":"格隆汇3月19日丨旺山旺水－Ｂ(02630.HK)宣布，公司将于2026年3月31日(星期二)举行董事会会议，藉以(其中包括)考虑及批准集团截至2025年12月31日止年度的全年业绩及其发布，并考虑派发末期股息(如有)，以及处理其他事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260319/32079406.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134238957","title":"旺山旺水-B（02630）2026年2月股份变动月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1134238957","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134238957?lang=zh_cn&edition=full","pubTime":"2026-03-05 06:05","pubTimestamp":1772661947,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司于2026年3月5日发布截至2026年2月28日的股份变动月报表。报告显示，公司当月无新增发行、购回或注销股份，整体股本保持稳定。公司已发行H股数量维持为66,677,133股，面值1元人民币，总注册股本为人民币66,677,133元；非上市股份数量则维持在100,920,667股，面值同为1元人民币，对应注册股本人民币100,920,667元。截至报告期末，公司注册股本总额为人民币167,597,800元。本次月报由董事会秘书兼联席公司秘书郭婷签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vigonvita.cn","stockEarnings":[{"period":"1week","weight":0.2437},{"period":"1month","weight":0.1375},{"period":"3month","weight":-0.2109},{"period":"6month","weight":-0.3106},{"period":"1year","weight":0.9958},{"period":"ytd","weight":-0.1863}],"compareEarnings":[{"period":"1week","weight":0.0325},{"period":"1month","weight":0.0505},{"period":"3month","weight":-0.0394},{"period":"6month","weight":-0.0562},{"period":"1year","weight":0.0055},{"period":"ytd","weight":-0.0194}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"苏州旺山旺水生物医药股份有限公司是一家主要从事发现、开发和商业化小分子药物的中国公司。该公司主要专注于神经精神、生殖健康及病毒感染治疗领域。该公司的产品管线主要包括LV232, TPN102, VV119, VV147, TPN171, VV913, VV116, VV261和VV207。该公司已进入商业化阶段。该公司主要在中国及乌兹别克斯坦经营其业务。","exchange":"SEHK","name":"旺山旺水-B","nameEN":"VIGONVITA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"旺山旺水-B(02630)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供旺山旺水-B(02630)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"旺山旺水-B,02630,旺山旺水-B股票,旺山旺水-B股票老虎,旺山旺水-B股票老虎国际,旺山旺水-B行情,旺山旺水-B股票行情,旺山旺水-B股价,旺山旺水-B股市,旺山旺水-B股票价格,旺山旺水-B股票交易,旺山旺水-B股票购买,旺山旺水-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"旺山旺水-B(02630)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供旺山旺水-B(02630)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}